Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;34(6):1013-1026.
doi: 10.1038/s41433-019-0608-7. Epub 2019 Oct 3.

A new era for giant cell arteritis

Affiliations
Review

A new era for giant cell arteritis

H S Lyons et al. Eye (Lond). 2020 Jun.

Abstract

The landscape of the investigation and management of giant cell arteritis (GCA) is advancing. In this review we will outline the recent advances by searching the current English literature for relevant articles using key words of giant cell arteritis, temporal arteritis, Horton's disease, investigation, and treatment. Delay in diagnosis, diagnostic uncertainty and glucocorticoid (GC) morbidity are among the highest concerns of clinicians and patients in this disease area. The positive news is that fast track pathways, imaging techniques and new therapies are emerging for routine management of GCA. Future directions for intervention in the treatment paradigm will be discussed.

摘要: 巨细胞动脉炎 (GCA) 的诊疗发生了很大进展。在这篇综述中, 我们通过关键词搜索目前相关的英文文献, 以总结和回顾巨细胞动脉炎的最新进展。所使用的关键词为巨细胞动脉炎; 颞动脉炎; 霍顿病;观察;治疗等。在GCA疾病领域内, 临床医生和患者们最关注的问题是诊断延迟, 诊断不确定性和糖皮质激素 (GC) 的使用情况。好消息是诊疗快速通道的建立, 成像技术以及新治疗的日新月异已经应用于GCA的常规管理。在本文中我们也会探讨治疗、干预策略的新方向。.

PubMed Disclaimer

Conflict of interest statement

SPM has undertaken consultancy work (speaker and advisory board fees) from Roche. VQ has undertaken consultancy work (speaker and advisory board fees) for Roche. Other authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Prominent, beaded, pulseless, tender temporal artery in a patient with biopsy proven giant cell arteritis. Abnormality detected by patient 3 weeks prior to new-onset temporary, then permanent double vision, followed by anterior ischaemic optic neuropathy and complete loss of vision to perception of light
Fig. 2
Fig. 2
Diagram of frequency of symptoms of GCA and the American College of Rheumatology (ACR) 1990 criteria for the definite diagnosis of GCA [30, 100, 101]
Fig. 3
Fig. 3
These are Temporal artery ultrasound images showing (a) longitudinal and (b) cross sectional images of a normal artery; (c) longitudinal and (d) cross section image of the non-compressible, hypoechoic “halo sign” (white asterisks)
Fig. 4
Fig. 4
A 67-year-old Caucasian lady presented with headache, PMR, drenching night sweats, weight loss and CRP 120. 18FDGPET-CT fused images show 18FDG avid large-vessel GCA (white arrows) of the thoracic aorta in sagittal (a), coronal (b) and transverse view (c). Inflammatory activity extends into the subclavian and common carotid arteries (d)
Fig. 5
Fig. 5
Key histopathological features of GCA. a H&E ×100, superficial temporal artery with marked intimal thickening. b Thick arrow head denotes inflammatory cells in the media and adventitia
Fig. 6
Fig. 6
Key histopathological feature of GCA with EHVG stain ×200 thick arrow head points to fragments of internal elastic laminae remaining and duplication
Fig. 7
Fig. 7
Key histopathological feature of healed arteritis. a Thick arrow head shows calcification at the intima media border and b an elastic stain (EHVG) highlights significant disruption of the internal elastic lamina with defects extending over 30–50% of the circumference of the artery
Fig. 8
Fig. 8
Percentage of new co-morbidities or adverse events recorded following a diagnosis of GCA cohort as adpated from Proven et al. [71]

Comment in

References

    1. Buttgereit F, Dejaco C, Matteson E, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315:2442–58. - PubMed
    1. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003;349:160–9. - PubMed
    1. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371:50–7. - PMC - PubMed
    1. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:633–9. - PMC - PubMed
    1. Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology. 2017;56:506–15. - PubMed

Publication types

MeSH terms

Substances